DK0981644T3 - APC mutation, der står i forbindelse med familierelateret colorectal cancer hos Ashkenazi -jøder - Google Patents

APC mutation, der står i forbindelse med familierelateret colorectal cancer hos Ashkenazi -jøder

Info

Publication number
DK0981644T3
DK0981644T3 DK98903558T DK98903558T DK0981644T3 DK 0981644 T3 DK0981644 T3 DK 0981644T3 DK 98903558 T DK98903558 T DK 98903558T DK 98903558 T DK98903558 T DK 98903558T DK 0981644 T3 DK0981644 T3 DK 0981644T3
Authority
DK
Denmark
Prior art keywords
colorectal cancer
family
ashkenazi jews
mutation associated
apc mutation
Prior art date
Application number
DK98903558T
Other languages
English (en)
Inventor
Steve Laken
Stephen Gruber
Gloria Petersen
Kenneth Kinzler
Bert Vogelstein
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of DK0981644T3 publication Critical patent/DK0981644T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98903558T 1997-01-31 1998-01-21 APC mutation, der står i forbindelse med familierelateret colorectal cancer hos Ashkenazi -jøder DK0981644T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/791,883 US5879890A (en) 1997-01-31 1997-01-31 APC mutation associated with familial colorectal cancer in Ashkenazi jews
PCT/US1998/000961 WO1998033940A1 (en) 1997-01-31 1998-01-21 An apc mutation associated with familial colorectal cancer in ashkenazi jews

Publications (1)

Publication Number Publication Date
DK0981644T3 true DK0981644T3 (da) 2003-08-25

Family

ID=25155083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98903558T DK0981644T3 (da) 1997-01-31 1998-01-21 APC mutation, der står i forbindelse med familierelateret colorectal cancer hos Ashkenazi -jøder

Country Status (11)

Country Link
US (2) US5879890A (da)
EP (1) EP0981644B1 (da)
AT (1) ATE240407T1 (da)
AU (1) AU6030498A (da)
CA (1) CA2278781A1 (da)
DE (1) DE69814622T2 (da)
DK (1) DK0981644T3 (da)
ES (1) ES2200311T3 (da)
IL (1) IL131167A (da)
PT (1) PT981644E (da)
WO (1) WO1998033940A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643722A (en) 1994-05-11 1997-07-01 Trustees Of Boston University Methods for the detection and isolation of proteins
US6210941B1 (en) 1997-06-27 2001-04-03 The Trustees Of Boston University Methods for the detection and isolation of proteins
CA2239733C (en) † 1995-12-18 2001-04-03 Myriad Genetics, Inc. Chromosome 13-linked breast cancer susceptibility gene
US5879890A (en) * 1997-01-31 1999-03-09 The Johns Hopkins University APC mutation associated with familial colorectal cancer in Ashkenazi jews
DE69914770T2 (de) 1998-08-20 2005-05-12 The Johns Hopkins University School Of Medicine Mitochondriale, als tumormarker geeignete mutationen, die nur ein basenpaar betreffen
DE19848665A1 (de) * 1998-10-22 2000-04-27 Bayer Ag Ein automatisierbarer Schnelltest zum direkten Nachweis der APC Resistenz Mutation mit spezifischen Primern und Probes
AU5460500A (en) 1999-06-04 2000-12-28 Massachusetts Institute Of Technology Compositions and methods for the screening of compounds to enhance or reduce apoptosis
US6306628B1 (en) 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
WO2004090547A2 (en) * 2003-04-04 2004-10-21 Protein Design Labs, Inc. Metastatic colorectal cancer signatures
DE10345021A1 (de) * 2003-09-23 2005-05-04 Univ Potsdam Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen
CN116507741A (zh) * 2020-08-20 2023-07-28 基因组评论股份有限公司 年龄相关性黄斑变性诊断用生物标记物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
ATE199746T1 (de) * 1991-01-16 2001-03-15 Univ Johns Hopkins Geerbte und somatische mutationen des apc-gens bei menschlichem colorectal-krebs
WO1994020616A1 (en) * 1993-03-05 1994-09-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas
EP0689606A1 (en) * 1993-03-19 1996-01-03 The Johns Hopkins University ANTIBODIES AND ASSAYS FOR DETERMINING MUTATIONS IN THE $i(APC) GENE
US5591826A (en) * 1993-05-05 1997-01-07 The Johns Hopkins University Human MSH2 protein
US5709998A (en) * 1993-12-15 1998-01-20 The Johns Hopkins University Molecular diagnosis of familial adenomatous polyposis
US5879890A (en) * 1997-01-31 1999-03-09 The Johns Hopkins University APC mutation associated with familial colorectal cancer in Ashkenazi jews

Also Published As

Publication number Publication date
AU6030498A (en) 1998-08-25
ES2200311T3 (es) 2004-03-01
US6013461A (en) 2000-01-11
ATE240407T1 (de) 2003-05-15
DE69814622D1 (de) 2003-06-18
EP0981644A1 (en) 2000-03-01
DE69814622T2 (de) 2004-02-26
CA2278781A1 (en) 1998-08-06
IL131167A (en) 2002-02-10
PT981644E (pt) 2003-09-30
US5879890A (en) 1999-03-09
IL131167A0 (en) 2001-01-28
EP0981644B1 (en) 2003-05-14
WO1998033940A1 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
ATE198623T1 (de) Verfahren zum nachweis von prädisposition von ovarial- und brustkrebs
DE69510410D1 (de) Proteinkinase
ATE267394T1 (de) Nachweis der krankheitsbedingten konformation eines proteins
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
NO862908L (no) In situ bestemmelse av totalt karbon og vurdering av steinkilde fra dette.
DK0705903T3 (da) Mutationer i det 17q-koblede bryst- og ovariecancerprædisponeringen
ATE458831T1 (de) Verfahren zum nachweis von lungenneoplasmen in fäkalen proben
ATE315231T1 (de) Verfahren zur feststellung der anwesenheit mutierten brca proteins
PT981644E (pt) Mutacao apc associada com o cancro colorectal familiar em judeus ashkenazi
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
DE69938867D1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
ATE299529T1 (de) Ptc gene und ihre verwendung
DE69932845D1 (de) Methoden zur quantifizierung von hla-dr und cd11b
ATE166110T1 (de) Verfahren zum nachweis eines genetischen defektes, assoziert mit thrombose und/oder mangelhafter anticoagulanz-reaktion auf aktiviertem protein c
FI910822A7 (fi) Menetelmä DNA-polymeraasin määrittämiseksi kvantitatiivisesti ja siinäkäyttökelpoinen koepakkaus
DE69627770D1 (de) Verfahren zum Bestimmen der Gesamtchlormenge und Kit dafür
ATE186575T1 (de) Verfahren zur identifizierung von menschlichen und tierischen zellen mit der fähigkeit zu unbegrenzter proliferation oder zur tumorbildung
GR1000664B (el) Παρασκευη ενωσεων αντι-υπερχοληστερολαιμικης τετραζολης και ενδιαμεσων αυτων.
DE69716057D1 (de) Verfahren und zusammensetzungen zum nachweis von spleiss-mutationen in dihydropyremudine dehydrogenase
ATE264508T1 (de) Verfahren und sets zur detektion von endotoxinen
NO990872L (no) Verktöy og fremgangsmÕte for geologisk formasjonsevaluering og testing
DE69231710D1 (de) Tyrosinkinase
ATE320602T1 (de) Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE223576T1 (de) Methode zur identifizierung von verbindungen mit anxiolytischem potential